The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 06, 2018

Filed:

Mar. 08, 2016
Applicant:

Jiangsu Hengrui Medicine Co., Ltd., Lianyungang, Jiangsu, CN;

Inventors:

Guaili Wu, Jiangsu, CN;

Xiaohui Gao, Jiangsu, CN;

Lin Bian, Jiangsu, CN;

Junlei Jia, Jiangsu, CN;

Assignee:

Jiangsu Hengrui Medicine Co., Ltd., Lianyungang, Jiangsu, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/12 (2006.01); A61K 31/4412 (2006.01); C07D 213/82 (2006.01); C07D 405/12 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
C07D 401/12 (2013.01); A61K 31/4412 (2013.01); A61P 35/00 (2018.01); C07D 213/82 (2013.01); C07D 405/12 (2013.01); C07B 2200/13 (2013.01);
Abstract

Disclosed are a p-toluenesulfonate of a MEK kinase inhibitor, and a crystal form thereof and a preparation method thereof. Specifically disclosed are a 2-((2-fluorine-4-iodophenyl)amino)-1-methyl-4-((6-methylpyridine-3-group)oxygroup)-6-carbonyl-1,6-dihydropyridine-3-formamide p-toluenesulfonate (a compound represented by formula (I)), a crystal form I, and a preparation method thereof. The obtained crystal form I of the compound of formula (I) has good crystal form stability and chemical stability, and the crystallization solvent used has low toxicity and low residue, and is more suitable for use in clinical treatment.


Find Patent Forward Citations

Loading…